Subcellular distribution of the anticancer drug mitoxantrone in human and drug-resistant murine cells analyzed by flow cytometry and confocal microscopy and its relationship to the induction of DNA damage.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (35)
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
1989 • 2,060 citations
Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.
1984 • 896 citations
An evaluation of confocal versus conventional imaging of biological structures by fluorescence light microscopy.
1987 • 850 citations
Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.
1988 • 415 citations
Mitoxantrone: A New Anticancer Drug with Significant Clinical Activity
1986 • 288 citations
DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.
1986 • 241 citations
Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy.
1991 • 160 citations
Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257.
1990 • 148 citations
Experimental antitumor activity of aminoanthraquinones.
1979 • 131 citations
Interactions of antitumor agents ametantrone∗∗Trade name for the salt of 1,4-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione (Fig. 1, I). Abbreviations: HAQ, ANT; NSC-287513. and mitoxantrone (novatrone)††Trade name for the salt of 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino] -9,10- anthracenedione (Fig. 1, II). Abbreviation: DHAQ; NSC-279836 and NSC-301739. with double-stranded DNA
1985 • 124 citations
Cytofluorescence localization of adriamycin and daunorubicin.
1974 • 121 citations
Lysosomal localization and mechanism of uptake of Nile blue photosensitizers in tumor cells.
1991 • 106 citations
Relationship between the pharmacological activity of antitumor drugs Ametantrone and mitoxantrone (Novatrone) and their ability to condense nucleic acids.
1986 • 104 citations
Long-term inhibition of DNA synthesis and the persistence of trapped topoisomerase II complexes in determining the toxicity of the antitumor DNA intercalators mAMSA and mitoxantrone.
1990 • 81 citations
Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene.
1985 • 73 citations
Cellular consequences of overproduction of DNA topoisomerase II in an ataxia-telangiectasia cell line.
1989 • 71 citations
High Field1H-NMR Analysis of the 1:1 Intercalation Complex of the Antitumor Agent Mitoxantrone and the DNA Duplex [d(CpGpCpG)]2
1985 • 68 citations
Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.
1984 • 68 citations
Mitoxantrone-DNA binding and the induction of topoisomerase II associated DNA damage in multi-drug resistant small cell lung cancer cells
1990 • 65 citations
Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A
1989 • 62 citations
Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin)
1990 • 57 citations
Evidence for human liver mediated free-radical formation by doxorubicin and mitozantrone.
1985 • 51 citations
Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
1988 • 47 citations
DNA sequence preferences for the anti‐cancer drug mitoxanthrone and related anthraquinones revealed by DNase I footprinting
1986 • 43 citations
Selective displacement of nuclear proteins by antitumor drugs having affinity for nucleic acids.
1989 • 36 citations
The in vitro effects and cross-resistance patterns of some novel anthracyclines
1986 • 33 citations
Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy.
1983 • 28 citations
Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line
1989 • 23 citations
Therapy of adult acute lymphocytic leukemia.
1984 • 23 citations
Development of Resistance and Characteristics of a Human Colon Carcinoma Subline Resistant to Mitoxantrone in vitro
1987 • 20 citations
Reduced nuclear binding of a DNA minor groove ligand (Hoechst 33342) and its impact on cytotoxicity in drug resistant murine cell lines
1990 • 17 citations
Alteration of binding of the supravital dye Hoechst 33342 to human leukemic cells by adriamycin.
1978 • 16 citations
Chromatin modifications associated with N-methylformamide-induced radiosensitization of clone A cells.
1988 • 14 citations
A linear transform of the multi-target survival curve
1978 • 14 citations
Studies on the fluorescence labeling of human red blood cell membrane ghosts with 4′-(9-acridinylamino) methanesulfon-m-anisidide
1985 • 4 citations